Michigan Medicine names executive vice dean for research, chief scientific officer

Steve Kunkel has long history leading research at U-M

Author | Kelly Malcom

Steve Kunkel, Ph.D., has been appointed as the permanent executive vice dean for research and chief scientific officer for Michigan Medicine, effective Sept. 1.

Kunkel has served in this role in an interim capacity since October 2018 for Michigan Medicine, the academic medical center of the University of Michigan.

Kunkel will be instrumental in collaborating with the research community to develop long-term strategies to grow and advance discovery science at Michigan Medicine. This will include partnerships across the U-M campus to further initiatives like precision health and the biosciences.  

Since 1980, Kunkel has a long and robust history with U-M, including roles as the senior associate dean for research, Endowed Professor of Pathology Research and the Peter A. Ward Distinguished University Professor. He has also held various leadership and administrative positions, including the associate dean for interdisciplinary studies in the Horace Rackham Graduate School, interim dean of the Horace H. Rackham Graduate School and interim vice provost for academic affairs. 

His research interests have centered on assessing molecular mechanisms of lung inflammation by studying cytokine and chemokine biology. His studies are internationally recognized. His research group has provided evidence for specific cytokine phenotypes that dictate the progression of particular chronic diseases.

He has co-authored more than 600 peer-reviewed manuscripts, contributed more than 60 chapters to different books in his field and served as the editor for four books. He's also presented more than 150 lectures as a visiting professor/lecturer in the past 10 years, maintained continuous funding of multiple National Institute of Health grants for a number of years, including the principal investigator of a program project to study lung inflammation and a recipient of a previous NIH MERIT Award and served on National Institute of Health peer review study sections.

Kunkel also has organized numerous international conferences on inflammation, and is an associate editor for various professional scientific journals. He is the present co-chair of the Board of Scientific Counselors for the NIAID-NIH.

He received his Ph.D. degree in 1978 in microbiology from the University of Kansas. After a short appointment in Connecticut, he joined the faculty at U-M in 1980 as an instructor in pathology. He was promoted to professor with tenure in 1991.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories 10 year old boy leaning against tree and posing with his mom and sisters outside
Health Lab
Family travels over 1,000 miles for son’s heart transplant
Family travels over 1,000 miles for son's heart transplant and ongoing heart care
Scientific illustration of gliobastoma cells in the brain
Health Lab
Path forward for glioblastoma treatment
Experts in brain cancer outline current discoveries and offer a path of hope for glioblastoma treatment
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Period Poverty and the Need to Make Menstruation Products Easier to Access
A survey focused on how much people in their teens and early 20s know about periods and their experience and attitudes around “period poverty”.
Health care provider with stethoscope holds patient's hand
Health Lab
Opinion: Hospice care for those with dementia falls far short of meeting people’s needs at the end of life
An end-of-life care specialist discusses the shortfalls of hospice care coverage for people with dementia, using the experience of former President Jimmy Carter and former First Lady Rosalynn Carter as examples.
Xray of a stem cell in a mouse brain.
Health Lab
Stem cells improve memory, reduce inflammation in Alzheimer’s mouse brains
Researchers improved memory and reduced neuroinflammation in a mouse model of Alzheimer’s Disease, suggesting another avenue for potential treatment.
Illustration of a microscope
Health Lab
Researchers uncover distinct molecular subgroups of kidney disease for personalized treatment
Researchers have used advanced computer algorithms to uncover distinct molecular subgroups of kidney diseases, independent of clinical classifications. These findings have significant implications for personalized treatment approaches.